Profile | GDS4284 / 1565717_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2571.17 | 87 |
GSM687648 | Patient 402 control | 876.511 | 72 |
GSM687653 | Patient 403 control | 2990.45 | 89 |
GSM687658 | Patient 404 control | 2151.14 | 85 |
GSM687663 | Patient 411 control | 3267.6 | 90 |
GSM687668 | Patient 422 control | 3402.83 | 90 |
GSM687673 | Patient 424 control | 2739.86 | 88 |
GSM687678 | Patient 425 control | 3619.2 | 91 |
GSM687683 | Patient 427 control | 2207.76 | 85 |
GSM687688 | Patient 428 control | 3225.29 | 89 |
GSM687695 | Patient 441 control | 623.036 | 66 |
GSM687699 | Patient 443 control | 1665.15 | 82 |
GSM687704 | Patient 444 control | 2851.83 | 88 |
GSM687707 | Patient 448 control | 3314.19 | 90 |
GSM687712 | Patient 449 control | 1860.23 | 83 |
GSM687719 | Patient 450 control | 2030.91 | 84 |
GSM687724 | Patient 451 control | 2226.3 | 86 |
GSM687728 | Patient 452 control | 2334.86 | 86 |
GSM687646 | Patient 401 treated 24h | 3543.37 | 90 |
GSM687649 | Patient 402 treated 24h | 2122.1 | 84 |
GSM687665 | Patient 411 treated 24h | 2113.76 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 2622.35 | 87 |
GSM687667 | Patient 411 treated 4 weeks | 3236.69 | 89 |
GSM687670 | Patient 422 treated 24h | 3554.19 | 90 |
GSM687671 | Patient 422 treated 4 weeks | 4161.2 | 92 |
GSM687654 | Patient 403 treated 24h | 3007.35 | 89 |
GSM687675 | Patient 424 treated 24h | 3112.43 | 89 |
GSM687685 | Patient 427 treated 24h | 2237.07 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 4366.88 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 3361.72 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 4175.31 | 92 |
GSM687692 | Patient 428 treated 4h | 1975.74 | 84 |
GSM687716 | Patient 449 treated 4h | 2508.53 | 87 |
GSM687722 | Patient 450 treated 4h | 1274.15 | 78 |
GSM687680 | Patient 425 treated 24h | 2372.12 | 86 |
GSM687690 | Patient 428 treated 24h | 1417.46 | 79 |
GSM687700 | Patient 443 treated 24h | 1733.1 | 82 |
GSM687705 | Patient 444 treated 24h | 3987.17 | 91 |
GSM687714 | Patient 449 treated 24h | 2257.57 | 85 |
GSM687721 | Patient 450 treated 24h | 1264.76 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 1801.04 | 82 |
GSM687694 | Patient 428 treated 4 weeks | 1983.92 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 2075.72 | 84 |
GSM687718 | Patient 449 treated 4 weeks | 1817.73 | 83 |
GSM687723 | Patient 450 treated 4 weeks | 1798.41 | 83 |
GSM687661 | Patient 404 treated 4h | 2257.17 | 85 |
GSM687710 | Patient 448 treated 4h | 4406.18 | 92 |
GSM687726 | Patient 451 treated 4h | 3447.17 | 90 |
GSM687730 | Patient 452 treated 4h | 36.6493 | 7 |
GSM687660 | Patient 404 treated 24h | 1025.47 | 76 |
GSM687697 | Patient 441 treated 24h | 1444.46 | 80 |
GSM687709 | Patient 448 treated 24h | 3884.28 | 91 |
GSM687725 | Patient 451 treated 24h | 3354.02 | 90 |
GSM687729 | Patient 452 treated 24h | 1266.19 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 3157.59 | 89 |
GSM687731 | Patient 452 treated 4 weeks | 2510.65 | 87 |